Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma
A phase 3 trial of Percutaneous hepatic perfusion in Uveal melanoma, run by Delcath Systems Inc., completed.
Overview
Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma is a phase 3 interventional study registered as NCT02678572 by Delcath Systems Inc., with 102 participants recorded, started 2016-02-01 and reaching its primary completion in 2023-05-18. Interventions recorded: Melphalan/HDS. Conditions recorded: Ocular Melanoma, Uveal Melanoma.
Linked to the technology Percutaneous hepatic perfusion because the registry's title names it ("percutaneous hepatic perfusion") and Uveal melanoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialPHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver Metastases
Shares Percutaneous hepatic perfusion (chemosaturation), Uveal melanoma and the tag pipeline.
- TrialAn Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma
Shares Delcath Systems, Percutaneous hepatic perfusion (chemosaturation), Melphalan (including hepatic delivery system), Uveal melanoma.
- TrialEvaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
Shares Uveal melanoma and the tag pipeline.
- TrialA Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Shares Melphalan (including hepatic delivery system) and the tag pipeline.
- TrialPrevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated with Proton Therapy for a Large Choroidal Melanoma
Shares Uveal melanoma and the tag pipeline.
- TrialA Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
Shares Uveal melanoma and the tag pipeline.
- TrialPanobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma
Shares Melphalan (including hepatic delivery system) and the tag pipeline.
- TrialA Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
Shares Uveal melanoma and the tag pipeline.